Maxcyte Inc

Maxcyte (MXCT)

Company name:Maxcyte Inc
Company Description:MaxCyte is an established and revenue generating US-based developer and supplier of cell engineering technology to biotechnology and pharmaceutical firms engaged in cell therapy, drug discovery and development, biomanufacturing, gene editing and immuno-oncology
EPIC:MXCTTrading Currency:GBX
Market Sector:AMQ1ISIN:
Market Segment:ASQ1Share Type:DE
WWW Address: STK USD0.01 (DI)
 Price Price Change [%] Bid Offer Open High Low Volume
 120.00 0.0 [0.00] 117.00 123.00 120.00 120.00 120.00 822
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 61.60 51.33 0.21 -12.94 - - - 196.00 - 105.00

Maxcyte Key Figures

(at previous day's close)
Market Cap.61.60m
Shares In Issue51.33m
Prev. Close120.00
PE Ratio- 
Dividend Yield-%
EPS - basic-12.94p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-16.02p
Return On Equity (ROE)-72.21%
Operating Margin-53.21%
PEG Factor- 
EPS Growth Rate15.00%
Dividends PS Growth Rate-%
Net Debt0.58m
Gross Gearing49.39%
Quick Assets13.34m
Net Working Capital9.95m
Intangibles / Fixed Assets-%
Turnover PS25.46p
Pre-Tax Profit PS-13.55p
Retained Profit PS-13.55p
Cash PS17.18p
Net Cash PS7.14p
Net Tangible Asset Value PS *18.76p
Net Asset Value PS18.76p
Spread6.00 (4.88%) 

Maxcyte Balance Sheet


Share Price Performance

Sample Period HighLow
1 week122.00111.00
4 weeks122.50105.00
12 weeks127.00105.00
1 year196.00105.00

Share Price Chart (5 years)

Maxcyte Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week113.007.006.19111.000.01119.27
4 weeks107.5012.5011.63105.000.15110.73
12 weeks122.00-2.00-1.64105.000.05111.44
26 weeks167.50-47.50-28.36105.000.05115.26
1 year189.50-69.50-36.68105.000.04122.55
3 years135.50-15.50-11.44105.000.03175.71
5 years72.5047.5065.5272.500.02171.53

Maxcyte Key Management Ratios

Maxcyte Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 2.21 
Tobin's Q Ratio (excl. intangibles)2.21 
Dividend Yield-%
Market-to-Book Ratio6.40 
Price-to-Pre-Tax Profit PS-8.86 
Price-to-Retained Profit PS-8.86 
Price-to-Cash Flow PS-7.49 
Price-to-Sales PS4.71 
Price-to-Net Tangible Asset Value PS6.40 
Price-to-Cash PS6.98 
Net Working Capital PS19.38 
Price Pct to Working Capital PS6.19%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Maxcyte Financial Ratios

(Leverage Ratios)
Debt Ratio30.59%
Debt-to-Equity Ratio0.44 
Debt-to-Equity Ratio (excl. Intgbl)0.44 
Debt-to-Equity Market Value0.07 
Net Gearing3.04%
Net Gearing (excl. Intangibles)3.04%
Gross Gearing49.39%
Gross Gearing (excl. Intangibles)49.39%
Gearing Under 1 Year27.08%
Gearing Under 1 Year (excl. Intgbl)27.08%
(Liquidity Ratios)
Net Working Capital to Total Assets52.28%
Current Ratio2.93 
Quick Ratio (Acid Test)2.59 
Liquidity Ratio1.71 
Cash & Equiv/Current Assets58.40%
(Solvency Ratios)
Enterprise Value57.02m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.15 
Total Debt/Sales0.72 
Total Debt/Pre-Tax Profit-1.35 
Total Debt9.40m
Total Debt/Net Current Assets0.94%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Maxcyte Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-50.12%
Return On Assets (ROA)-24.99%
Net Profit Margin-53.21%
Assets Turnover0.47 
Return On Equity (ROE)-72.21%
Return On Investment (ROI)-33.23%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-53.21%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.82 
Fixed Assets Turnover4.46 
Current Assets Turnover0.52 
Net Working Capital Turnover 
Inventory Turnover7.28 
(Other Operating Ratios)
Total Assets-to-Sales2.13 
Debt Collection Period113.11Days

Maxcyte Dividends

Sorry No Data Available

Maxcyte Fundamentals

 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
pre tax profit-1.45-15.56%-3.35-27.27%-9.92-79.13%-8.87-53.21%m
attributable profit-3.52-37.87%-3.85-31.39%-9.92-79.13%-8.87-53.21%m
retained profit-3.52-37.87%-3.85-31.39%-9.92-79.13%-8.87-53.21%m
eps - basic-186.00 -11.00 -20.00 -17.00 
eps - diluted-186.00 -11.00 -20.00 -17.00 
dividends per share- - - - 

Maxcyte Balance Sheet

 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
fixed assets fixed assets0.213.24%0.281.75%0.852.70%1.827.49%m
intangibles intangibles--%--%--%--%m
fixed investments fixed investments--%--%--%3.1913.15%m
current assets - other current assets - other1.2419.44%0.321.98%0.672.12%0.863.56%m
stocks stocks1.0916.96%1.338.30%1.354.29%2.249.24%m
debtors debtors1.4522.67%2.4115.00%3.2010.18%4.9020.21%m
cash & securities cash & securities2.4137.68%11.7372.96%25.3480.71%11.2546.35%m
creditors - short creditors - short5.0979.54%5.6535.17%7.2423.06%6.5727.08%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other4.3968.62%5.3433.21%4.5614.53%5.4122.31%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves-48.36-755.50%5.0831.63%19.6062.41%12.2850.61%m
prefs, minorities prefs, minorities45.28707.35%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Maxcyte Cash Flow Statement

31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
Operating CF-0.18-2.34-9.68-10.49m
Pre-Financing CF-0.28-2.55-10.29-14.32m
Retained CF-1.009.3213.61-14.09m

Maxcyte Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191208 03:19:02